Articles tagged "Kidney transplantation"

2015 American Transplant Congress
The Characteristics of Post-Operative Deep Vein Thrombosis in Kidney Transplant Recipients – Difference from Other Type of Surgery
J. Kim,¹ I. Moon,¹ M.-H. Kim,¹ K. Park,² S. Ahn,³ S. Park,⁴ S.-D. Kim,⁵ S. Kim.⁶
¹Surgery, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea; ²Surgery, Inha University, Incheon, Republic of Korea; ³Surgery, Yeouido St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea; ⁴Surgery, Uijeongbu St Mary's Hospital, Seoul, Republic of Korea; ⁵Surgery, Incheon St Mary's Hospital, Incheon, Republic of Korea; ⁶Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
Background Deep vein thrombosis (DVT) is a severe and common complication that occurs after a major operation. Despite the commonality of DVT, there is limited…
2015 American Transplant Congress
Associations Between Deceased-Donor Urine Biomarkers of Kidney Injury and 6-Month Kidney Transplant Function
C. Parikh, I. Hall, M. Doshi, B. Schroppel, F. Weng, R. Hasz, P. Murray, V. Rao, H. Thiessen-Philbrook, J. Ficek, P. Reese.
TRIBE-AKI Consortium, New Haven, CT.
Assessment of organ quality is integral to allocation, yet existing tools have a limited ability to predict important transplant outcomes. We evaluated whether injury biomarkers,…
2015 American Transplant Congress
Fracture Incidence in Adult Kidney Transplant Recipients
K. Naylor,^1,2 S. Jamal,³ G. Zou,¹ E. McArthur,⁴ N. Lam,^1,2 W. Leslie,⁵ A. Hodsman,² J. Kim,^4,6 G. Knoll,⁷ L.-A. Fraser,¹ J. Adachi,⁸ A. Garg.^1,2,4
¹Western University, London, ON, Canada; ²London Health Sciences Centre, London, ON, Canada; ³Women's College Research Institute, Toronto, Canada; ⁴Institute for Clinical Evaluative Sciences, Toronto, Canada; ⁵University of Manitoba, Winnipeg, Canada; ⁶University Health Network, Toronto, Canada; ⁷Ottawa Hospital Research Institute, Ottawa, Canada; ⁸McMaster University, Hamilton, Canada.
Background: It remains uncertain whether kidney transplant recipients are a high risk group for fracture. We conducted this study to provide a precise estimate of…
2015 American Transplant Congress
HLA-DR Matching Improves Immunologic Outcomes in Elderly Kidney Transplant Recipients
F. Halleck, D. Khadzhynov, L. Liefeldt, P. Glander, J. Bamoulid, S. Kreimer, L. Lehner, K. Budde, O. Staeck.
Nephrology, Charité Universitätsmedizin Berlin, Berlin, Germany.
BACKGROUND: The Eurotransplant senior program (ESP) neglects HLA matching for elderly (>65y) KTR. Only few data exist regarding the influence of HLA-DR-matching on immunologic outcomes.PATIENTS…
2015 American Transplant Congress
24 Month Post Transplantation Follow Up of the Certitem Trial
E. Rondeau,¹ E. Cassuto,² V. Vuiblet,³ C. Legendre,⁴ P. Merville,⁵ Y. Le Meur,⁶ B. Moulin,⁷ P. Westeel,⁸ B. Hurault De Ligny,⁹ A. Lécuyer,¹⁰ M. Tindel,¹¹ N. Kamar.¹²
¹Hôpital Tenon, Paris, France; ²Hôpital Pasteur, Nice, France; ³Hôpital Maison Blanche, Reims, France; ⁴Hôpital Necker, Paris, France; ⁵Hôpital Pellegrin, Bordeaux, France; ⁶Hôpital La Cavale Blanche, Brest, France; ⁷Nouvel Hôpital Civil, Strasbourg, France; ⁸Hôpital Sud, Amiens, France; ⁹CHU, Caen, France; ¹⁰Novartis Pharma S.A.S, Rueil-Malmaison, France; ¹¹Keyrus Biopharma, Levallois-Perret, France; ¹²Hôpital Rangueil, Toulouse, France.
Background: CERTITEM has evaluated the effect of everolimus/calcineurin inhibitors free (CNI free) on fibrosis progression and results have been reported at 12 months (M12). Data…
2015 American Transplant Congress
NFAT Regulated Cytokine Gene Expression for Immune Monitoring in Kidney Transplant Recipients
V. Tatapudi, A. Webber, C. Leung, F. Vincenti.
Div. of Nephrology, Dept. of Medicine, University of California, San Francisco Medical Center, San Francisco, CA.
Purpose of Study:To demonstrate that profiling kidney transplant recipients (KTR) on Tacrolimus (Tac) based immunosuppression based on quantitative analysis of NFAT (nuclear factor of activated…
2015 American Transplant Congress
Prognostic Relevance of Rejection Episodes Detected Within the First 3 Weeks After Kidney Transplantation
V. Arelin,¹ H. Schrem,² F. Lehner,² W. Gwinner,¹ H. Haller,¹ M. Schiffer.¹
¹Division of Nephrology and Hypertension, Department of Medicine, Hannover Medical School, Hannover, Lower Saxony, Germany; ²General, Visceral and Transplant Surgery, Hannover Medical School, Hannover, Lower Saxony, Germany.
Background:The relevance of cellular rejection events detected in the early phase after kidney transplantation for graft survival and function remains to be elucidated. Especially the…
2015 American Transplant Congress
Association of Transplant Volume and Survival in Pediatric Kidney Transplants
W. Cherikh,¹ A. Wilk,¹ C. Flavin,¹ E. Brewer.²
¹United Network for Organ Sharing, Richmond, VA; ²Baylor Coll Med & Texas Children's Hosp., Houston, TX.
Background. Center specific volume has been shown to correlate with outcomes for many procedures in the adult population. The current analysis was conducted to determine…
2015 American Transplant Congress
Racial Differences in Transplant and Waitlist Mortality Rates Among HIV+ Kidney Transplant Candidates
J. Locke,¹ S. Gustafson,² C. Durand,³ J. Snyder,² B. Shelton,¹ R. Reed,¹ P. MacLennan,¹ S. Mehta,¹ A. Nellore,¹ D. Segev.^2,3
¹University of Alabama, Birmingham, Birmingham, AL; ²SRTR, MMRF, Minneapolis, MN; ³Johns Hopkins Univerity, Baltimore, MD.
Kidney transplant (KT) is now a viable option for select HIV+ end-stage renal disease patients. As OPTN does not collect HIV status at waitlisting, no…
2015 American Transplant Congress
Disparities in Death and Delisting on the Waitlist for Renal Transplant in the United States
D. Keith, A. Nishio Lucar, G. Vranic.
Medicine, University of Virginia, Charlottesville, VA.
Waiting time to kidney transplant varies dramatically among organ procurement organizations (OPOs) in the US. We sought to evaluate the association between death and delisting…